51. Wong J. R., Harris J. K., Rodriguez-Galindo C., Johnson K. J. Incidence of childhood and adolescent melanoma in the United States: 1973-2009 // Pediatrics. ‒ 2013. ‒ T. 131, № 5. ‒ C. 846-54.
52. Nikfarjam J., Chambers E. Congenital Melanocytic Nevi and the Risk of Malignant Melanoma: Establishing a Guideline for Primary-Care Physicians // Einstein Journal of Biology and Medicine. ‒ 2016. ‒ T. 27. ‒ C. 59.
53. Yun S. J., Kwon O. S., Han J. H., Kweon S. S., Lee M. W., Lee D. Y., Kim M. B., Kim Y. C., Yoon T. Y., Chung K. Y., Kim I. H., Kim K. H., Suh K. S., Lee S. J., Seo Y. J., Kim K. H., Park H. J., Roh M. R., Ahn K. J., Yoon T. J., Kim M. H., Li K. S., Park J. S., Shin B. S., Ko J. Y., Ahn H. H., Kim H. J., Park S. D., Jang S. J., Won Y. H. Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective study // Br J Dermatol. ‒ 2012. ‒ T. 166, № 1. ‒ C. 115-23.
54. Coit D. G., Thompson J. A., Albertini M., Algazi A., Andtbacka R., Bichakjian C., Carson W. E., 3rd, Daniels G. A., DiMaio D., Fields R. C., Fleming M. D., Gastman B., Gonzalez R., Guild V., Johnson D., Joseph R. W., Lange J. R., Martini M. C., Margolin K., Olszanski A. J., Ott P. A., Gupta A., Ross M. I., Salama A. K., Skitzki J., Sosman J. A., Swetter S. M., Tanabe K. K., Torres-Roca J. F., Urist M., Engh A., McMillian N. NCCN Clinical Practice Guidelines in Oncology. Melanoma. Version 3.2018. ‒ National Comprehensive Cancer Network, Inc, 2018. ‒ Pages p. ‒.
55. Rat C., Grimault C., Quereux G., Dagorne M., Gaultier A., Khammari A., Dreno B., Nguyen J. M. Proposal for an annual skin examination by a general practitioner for patients at high risk for melanoma: a French cohort study // BMJ Open. ‒ 2015. ‒ T. 5, № 7. ‒ C. e007471.
56. Abbasi N. R., Shaw H. M., Rigel D. S., Friedman R. J., McCarthy W. H., Osman I., Kopf A. W., Polsky D. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria // JAMA. ‒ 2004. ‒ T. 292, № 22. ‒ C. 2771-6.
57. Fang P., Jiang W., Allen P., Glitza I., Guha N., Hwu P., Ghia A., Phan J., Mahajan A., Tawbi H., Li J. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma // J Neurooncol. ‒ 2017. ‒ T. 133, № 3. ‒ C. 595-602.
58. Grange F. [Multiple primary melanoma and familial melanoma. Risk evaluation and screening tests. How to evaluate the risk of developing a second melanoma? In what family? Should screening methods be implemented? Which ones and why?] // Ann Dermatol Venereol. ‒ 1995. ‒ T. 122, № 5. ‒ C. 365-71.
59. Claeson M., Holmstrom P., Hallberg S., Gillstedt M., Gonzalez H., Wennberg A. M., Paoli J. Multiple Primary Melanomas: A Common Occurrence in Western Sweden // Acta Derm Venereol. ‒ 2016.10.2340/00015555-2598.
60. Moore M. M., Geller A. C., Warton E. M., Schwalbe J., Asgari M. M. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011 // J Am Acad Dermatol. ‒ 2015. ‒ T. 73, № 4. ‒ C. 630-6.
61. De Giorgi V., Savarese I., D'Errico A., Gori A., Papi F., Colombino M., Sini M. C., Grazzini M., Stanganelli I., Rossari S., Covarelli P., Massi D., Palmieri G. Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients // Pigment Cell Melanoma Res. ‒ 2015. ‒ T. 28, № 6. ‒ C. 747-51.
62. Watts C. G., Dieng M., Morton R. L., Mann G. J., Menzies S. W., Cust A. E. Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review // Br J Dermatol. ‒ 2015. ‒ T. 172, № 1. ‒ C. 33-47.
63. Dinnes J., Deeks J. J., Grainge M. J., Chuchu N., Ferrante di Ruffano L., Matin R. N., Thomson D. R., Wong K. Y., Aldridge R. B., Abbott R., et al. Visual inspection for diagnosing cutaneous melanoma in adults // Cochrane Database of Systematic Reviews. ‒ 2018.10.1002/14651858.CD013194 № 12.
64. Nino M., Brunetti B., Delfino S., Brunetti B., Panariello L., Russo D. Spitz nevus: follow-up study of 8 cases of childhood starburst type and proposal for management // Dermatology. ‒ 2009. ‒ T. 218, № 1. ‒ C. 48-51.
65. Pizzichetta M. A., Talamini R., Marghoob A. A., Soyer H. P., Argenziano G., Bono R., Corradin M. T., De Giorgi V., Gonzalez M. A., Kolm I., Kopf A. W., Malvehy J., Nami N., Oliviero M., Pellacani G., Puig S., Rabinovitz H., Rubegni P., Seidenari S., Stanganelli I., Veronesi A., Zalaudek I., Zampieri P., Menzies S. W. Negative pigment network: an additional dermoscopic feature for the diagnosis of melanoma // J Am Acad Dermatol. ‒ 2013. ‒ T. 68, № 4. ‒ C. 552-559.
66. Zalaudek I., Kittler H., Hofmann-Wellenhof R., Kreusch J., Longo C., Malvehy J., Puig S., Moscarella E., Piana S., Massone C., Cota C., Ferrara G., Fleischer M., Argenziano G. "White" network in Spitz nevi and early melanomas lacking significant pigmentation // J Am Acad Dermatol. ‒ 2013. ‒ T. 69, № 1. ‒ C. 56-60.
67. Stapleton J. L., Turrisi R., Mallett K. A., Robinson J. K. Correspondence between pigmented lesions identified by melanoma patients trained to perform partner-assisted skin self-examination and dermatological examination // Cancer Epidemiol Biomarkers Prev. ‒ 2015. ‒ T. 24, № 8. ‒ C. 1247-53.
68. Duarte A. F., da Costa-Pereira A., Del-Marmol V., Correia O. Are General Physicians Prepared for Struggling Skin Cancer?-Cross-Sectional Study // J Cancer Educ. ‒ 2016.10.1007/s13187-016-1078-2.
69. Ilyas M., Costello C. M., Zhang N., Sharma A. The role of the ugly duckling sign in patient education // J Am Acad Dermatol. ‒ 2017. ‒ T. 77, № 6. ‒ C. 1088-1095.